Delivery Order SPE2DR25D2007-SPE2DR26FM26D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $26,399.23 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count units) on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count) with a ceiling value of $5,275.63. This competitive, non-set-aside delivery order represents a firm fixed price transaction with an ultimate completion date of July 29, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,968.48 for Dapagliflozin 10 mg tablets (30-count packaging) on November 14, 2025, with an ultimate completion date of November 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a specific pharmaceutical fulfillment under DLA's...
- The Defense Logistics Agency awarded a delivery order valued at $10,671.51 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 5 mg tablets (30-count) with a completion date of November 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The award represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,490.04 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count package). This competitively awarded, firm fixed-price delivery order was issued on November 14, 2025, with an ultimate completion date of November 17, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. No set-aside designation was applied to this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 5 mg tablets in quantities of 30 units, with a contract ceiling value of $1,761.68. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure and is scheduled for completion by October 30, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,332.72 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count units) under a firm fixed-price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by November 19, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count units) valued at $1,605.86. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a routine pharmaceutical supply transaction...
- The Defense Logistics Agency awarded a $1,110.60 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Dapagliflozin 10 mg, a common diabetes medication. This firm fixed price, non-set-aside contract was awarded on December 5, 2025, with an ultimate completion date of December 8, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count packaging) with a ceiling value of $7,756.44. This competitively awarded, firm fixed-price delivery order is not associated with any set-aside program and is scheduled for ultimate completion by August 7, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM26DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,850.88 to AmerisourceBergen Drug Corp for 30 tablets of Dapagliflozin 10 mg, with an ultimate completion date of December 15, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction under the company's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's comprehensive Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026) with DLA Troop Support Medical, which serves as a prime vendor vehicle for global pharmaceutical support to military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen supplies a broad range of medications, vaccines, and medical supplies to support defense health operations. The Dapagliflozin delivery represents one component of the company's extensive portfolio supplying critical diabetes and other therapeutic medications to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 12/11/25 |